Lv5
1280 积分 2025-04-02 加入
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
6小时前
已完结
Post-CAR-T Cell Therapy (Consolidation and Relapse): Acute Lymphoblastic Leukaemia
6小时前
已完结
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy
7小时前
已完结
Tumors of the breast
7小时前
已关闭
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy
7小时前
已完结
CD19-specific CAR-T cell therapy for relapsed/refractory non-B-cell acute leukaemia with CD19 antigen expression
14小时前
已完结
Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells
1天前
已完结
Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells
1天前
已完结
Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34
1天前
已关闭
皖公网安备34019202002308
